MYOCENE
Measuring muscle fatigue with precision for optimized athletic performance.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | €1.5m Valuation: €10.0m 162.6x EV/Revenue | Early VC | |
| Total Funding | 000k | ||
| EUR | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | - | 695 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | (5281 %) | (444 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Based in Liège, Belgium, Myocene is a sports and medical technology company established in 2020 by Dr. Pierre Rigaux. The firm is focused on providing objective measurements of muscle fatigue to elite athletes and professional sports teams. Myocene has secured a total of $5.36 million in funding over two rounds, with the latest seed round in June 2024 raising $3.21 million. Investors include InvestSud, Wallonie Entreprendre, and Noshaq.
The company's core offering is a portable device that quantifies muscle fatigue and performance. This system utilizes a combination of electrical stimulation to induce controlled muscle contractions and high-sensitivity force sensors to measure the response. Proprietary algorithms and artificial intelligence then analyze this data to compute a muscle fatigue index in approximately 90 to 120 seconds. This process provides an objective assessment without requiring voluntary exertion from the athlete. The device is designed for both indoor and outdoor use, targeting the quadriceps as a key indicator of overall leg and body muscle fatigue.
Myocene operates on a business model that involves selling its device and providing a cloud-based data service, reportedly through an annual license. Its clients are primarily elite sports organizations, including top European football clubs like Paris-Saint Germain, OGC Nice, and Sporting Club Braga, as well as the French Handball national team. By providing precise data, the technology allows strength and conditioning coaches to tailor training loads, manage recovery, optimize return-to-play protocols, and mitigate the risks of overtraining and injury. The company is expanding its commercial operations in European and American markets and has received FDA De Novo clearance, signaling potential applications in medical fields such as occupational medicine and the study of muscle pathologies.
Keywords: muscle fatigue measurement, sports technology, athlete performance monitoring, electrostimulation, force sensors, objective fatigue assessment, injury prevention, athletic training, recovery optimization, sports science, AI in sports, wearable devices, performance analytics, strength and conditioning, return-to-play, sports medicine, biomechanics, neurostimulation, quantitative sports data, elite athletics